A comparative study of four methods of establishing orthotopic human renal cell carcinoma models in nude mice

赵佩佩; 陈晓静; 王巧玲

doi:10.19401/j.cnki.1007-3639.2017.03.003

您当前的位置：

首页 >

文章列表页 >

A comparative study of four methods of establishing orthotopic human renal cell carcinoma models in nude mice

更新时间：2025-12-31

- A comparative study of four methods of establishing orthotopic human renal cell carcinoma models in nude mice
- China Oncology Vol. 27, Issue 3, Pages: 177-185(2017)
- 作者机构：
  
  1. 上海交通大学医学院附属仁济医院肾脏科,上海,200127
  2. 上海交通大学医学院附属仁济医院中心实验室,上海,200127
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.03.003
  CLC：
- Published Online：12 April 2017，
  
  Published：12 April 2017
- 稿件说明：
移动端阅览
赵佩佩,陈晓静,王巧玲,等. 4种人肾细胞癌原位移植裸鼠模型建立方法的比较[J]. 中国癌症杂志, 2017, 27(3): 177-185.

赵佩佩, 陈晓静, 王巧玲. A comparative study of four methods of establishing orthotopic human renal cell carcinoma models in nude mice[J]. China Oncology, 2017, 27(3): 177-185.
赵佩佩,陈晓静,王巧玲,等. 4种人肾细胞癌原位移植裸鼠模型建立方法的比较[J]. 中国癌症杂志, 2017, 27(3): 177-185. DOI： 10.19401/j.cnki.1007-3639.2017.03.003.

赵佩佩, 陈晓静, 王巧玲. A comparative study of four methods of establishing orthotopic human renal cell carcinoma models in nude mice[J]. China Oncology, 2017, 27(3): 177-185. DOI： 10.19401/j.cnki.1007-3639.2017.03.003.

摘要

背景与目的：肾细胞癌是最常见的肾脏恶性肿瘤，起病隐匿，恶性程度高。研究旨在建立成功率高、稳定的人肾细胞癌原位动物造模方法。方法：采用人肾细胞癌细胞(786-0、ACHN)进行细胞悬液原位注射法、皮下成瘤后引瘤原代细胞悬液原位注射法、皮下成瘤后引瘤组织块原位移植肾包膜下法及皮下成瘤后引瘤组织块原位移植肾周筋膜内法建立原位移植裸鼠模型，采用PET/CT、H-E染色、免疫组织化学染色及血清生化检测等手段观察成瘤率及肿瘤生长情况，评估4种方法的建模效果。结果：人肾细胞癌皮下移植瘤裸鼠模型，ACHN组成瘤率(90%)高于786-0组(30%)；人肾细胞癌原位移植裸鼠模型，786-0原位注射组、ACHN原位注射组、ACHN皮下移植瘤引瘤后原代细胞原位注射组、ACHN组织块肾包膜下包埋组和ACHN组织块肾周筋膜内包埋组的成瘤率分别为33%、80%、90%、100%和20%，其中以ACHN皮下成瘤后引瘤组织块原位移植肾包膜下法成瘤率最高，影像学及病理组织学检查结果显示符合低分化肾细胞癌。结论：成功建立4种人肾细胞癌原位移植裸鼠模型，其中以ACHN皮下成瘤后引瘤组织块原位移植肾包膜下法成瘤效果最佳，为肾细胞癌发病机制及靶向治疗的进一步研究提供理想的动物模型。

Abstract

Background and purpose: Renal cell carcinoma is the most common form of kidney cancer

characterized by lack of early symptoms and high malignancy. This study aimed to establish orthotopic nude mice models of human renal cell carcinoma with high success rate and good repeatability. Methods: The four types of methods which were adopted to establish the orthotopic models of renal cell carcinoma were orthotopic injection of 786-0 and ACHN cell suspensions

orthotopic injection of primary cell suspensions obtained from the subcutaneous tumor tissues

renal subcutis orthotopic implantation into renal capsule and surgical subcutis orthotopic implantation into renal fascia. To gain insights into the tumorigenicity and the growth of transplantation tumors

the imageological examination (PET/CT)

histological examination (H-E staining

immunohistochemistry staining) and biochemical analysis of blood were carried out. Results: In terms of the subcutaneous transplantation of human renal cell carcinoma models in nude mice

tumorigenic rate of ACHN cells (90%) was higher than that of 786-0 cells (30%). The tumorigenic incidences of 786-0 cell suspensions orthotopic injection

ACHN cell suspensions orthotopic injection

ACHN subcutis cellular suspensions orthotopic injection

ACHN subcutis orthotopic implantation into renal capsule and renal fascia were 33%

80%

90%

100% and 20%

respectively. ACHN subcutis orthotopic implantation into renal capsule was the most effective approach. Imageological and histological results accorded with poorly differentiated renal cell carcinoma. Conclusion: Four orthotopic nude mice models of human renal cell carcinoma were successfully established. Among these methods

ACHN subcutis orthotopic implantation into renal capsule is the most effective approach

which provides an ideal model for the research on biological behavior of human renal cell carcinoma and its treatment.

关键词

Keywords

references

Views

1501

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Evaluating the change of fatty acid synthesis in renal cell carcinoma by 18F-FAC microPET/CT imaging

A cohort study of prognostic value of ¹⁸F-FDG PET/CT metabolic parameters in patients with diffuse large B-cell lymphoma treated with CAR-T

Advances in the research, diagnosis and treatment of renal cell carcinoma in 2022

Value of pretreatment ¹⁸F-FLT PET/CT and ¹⁸F-FDG PET/CT uptake heterogeneity for early prediction of treatment outcome in locally advanced nasopharyngeal carcinoma

The value of¹⁸F-PSMA-1007 PET/CT in accurate assessment of newly diagnosed prostate cancer and its impact on clinical treatment decisions

Related Author

孙玉云

张　健

郑营营

Shengming DENG

Bin ZHANG

Yeye ZHOU

Chao HE

艾合太木江·安外尔

Related Institution

复旦大学附属肿瘤医院核医学科，复旦大学上海医学院肿瘤学系，复旦大学生物医学

影像研究中心，上海分子影像探针工程技术研究中心

复旦大学核物理与离子束应用教育部重点实验室

Department of Nuclear Medicine, the First Affiliated Hospital of Soochow University

Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰